Nav: Home

Study: Health care providers split on who should prescribe HIV prevention drug

April 30, 2019

BUFFALO, N.Y. -- Health care practitioners are split when it comes to opinions on which provider should take the lead in prescribing pre-exposure prophylaxis (PrEP), which is administered to people at high risk for HIV.

That's according to the findings of a new study by researchers from the University at Buffalo, who interviewed PrEP-prescribing providers to conduct a qualitative analysis of their perspectives on the preventive medication. Their paper was published online ahead of print earlier this month in the Journal of the Association of Nurses in AIDS Care.

In a separate study, UB researchers also surveyed pharmacy students about their knowledge of and views toward the medication.

"Understanding barriers and facilitators to PrEP adoption and implementation from both current and future health care providers is key to accelerate roll-out of this preventive medication to target populations who meet clinical eligibility criteria," said Sarahmona Przybyla, the study's lead author.

Przybyla is an assistant professor of community health and health behavior in UB's School of Public Health and Health Professions.

Who should prescribe PrEP?

In the U.S., there are more than 1.1 million people living with HIV, and 38,500 new infections occurring annually.

It has been seven years since the U.S. Food and Drug Administration approved PrEP for use in adults, and one year for adolescents. Still, previous research has shown that PrEP uptake has not met expectations. For example, the U.S. Centers for Disease Control and Prevention estimates that 1.2 million Americans are eligible for the drug, but only 150,000 take it.

PrEP is available only to people who are HIV negative. There's a debate -- dubbed the "purview paradox" -- within the health care and public health community about who should prescribe PrEP. While HIV specialists are likely to be the most willing and able to prescribe PrEP, they typically don't see HIV-uninfected patients. Meanwhile, primary care physicians are more likely to see eligible PrEP patients, but generalists may lack the training and skills necessary to prescribe it.

With this in mind, Przybyla and her team surveyed a small sample of clinicians in Erie and Niagara counties in Western New York who were licensed to prescribe medication in New York State, and who had prescribed PrEP for at least three months.

Participants were almost equally split on ideal provider type: 15 chose primary care physicians, while 13 said any health care provider. None of the participants indicated a preference for infectious disease or HIV specialists. That's likely because there are approximately 8,500 infectious disease specialists in the U.S., an insufficient number to treat the 1 million individuals who meet PrEP eligibility guidelines.

Previous studies of patients and health care providers have shown that primary care physicians are the preferred provider, largely because they're more available and accessible, and because they're more likely to see patients over a long period of time.

Clinicians are key stakeholders in PrEP engagement for patients at risk of HIV infection, according to Przybyla. "This research provides support for a growing foundation of research that warrants continued efforts to incorporate PrEP into a comprehensive HIV prevention plan at local, state, and national levels."

Surveying Rx students about PrEP

Przybyla is also the author of the first paper to survey pharmacy students about their knowledge of and attitudes toward PrEP. The study of 291 students enrolled in the pharmacy doctoral program (PharmD) in UB's School of Pharmacy and Pharmaceutical Sciences found that:
  • 89 percent agreed that PrEP can be a cost-effective tool to prevent HIV infection

  • 12 percent felt that PrEP is too expensive to justify its use

  • 16 percent felt that individuals prescribed the drug would not take it regularly

  • 64 percent felt confident they could counsel patients about PrEP

  • 87 percent reported that they intended to counsel patients about the drug
Other studies have examined PrEP attitudes among pharmacists, physicians, nurse practitioners and physician assistants, as well as medical students, but none have surveyed pharmacy students, Przybyla said.

The study, published online ahead of print in the journal Currents in Pharmacy Teaching and Learning, reveals a need for increased educational efforts to improve pharmacy students' knowledge of CDC prescription guidelines for the drug.

For example, 40 percent of respondents -- a higher proportion than in previous studies of health care providers -- erroneously believed that widespread use of PrEP could significantly increase rates of antiretroviral resistance.

CDC guidelines for clinicians provide detailed evidence that drug-resistant mutations are rare, researchers note.
-end-


University at Buffalo

Related Hiv Articles:

Defective HIV proviruses reduce effective immune system response, interfere with HIV cure
A new study finds defective HIV proviruses, long thought to be harmless, produce viral proteins and distract the immune system from killing intact proviruses needed to reduce the HIV reservoir and cure HIV.
1 in 7 people living with HIV in the EU/EEA are not aware of their HIV status
Almost 30,000 newly diagnosed HIV infections were reported by the 31 European Union and European Economic Area (EU/EEA) countries in 2015, according to data published today by ECDC and the WHO Regional Office for Europe.
Smoking may shorten the lifespan of people living with HIV more than HIV itself
A new study led by researchers at Massachusetts General Hospital finds that cigarette smoking substantially reduces the lifespan of people living with HIV in the US, potentially even more than HIV itself.
For smokers with HIV, smoking may now be more harmful than HIV itself
HIV-positive individuals who smoke cigarettes may be more likely to die from smoking-related disease than the infection itself, according to a new study published in the Journal of Infectious Diseases.
Patients diagnosed late with HIV infection are more likely to transmit HIV to others
An estimated 1.2 million people live with HIV in the United States, with nearly 13 percent being unaware of their infection.
The Lancet HIV: New HIV infections stagnating at 2.5 million a year worldwide
A major new analysis from the Global Burden of Disease 2015 study, published today in The Lancet HIV journal, reveals that although deaths from HIV/AIDS have been steadily declining from a peak in 2005, 2.5 million people worldwide became newly infected with HIV in 2015, a number that hasn't changed substantially in the past 10 years.
NIH scientists discover that defective HIV DNA can encode HIV-related proteins
Investigators from the National Institutes of Health have discovered that cells from HIV-infected people whose virus is suppressed with treatment harbor defective HIV DNA that can nevertheless be transcribed into a template for producing HIV-related proteins.
Study examines risk of HIV transmission from condomless sex with virologically suppressed HIV infection
Among nearly 900 serodifferent (one partner is HIV-positive, one is HIV-negative) heterosexual and men who have sex with men couples in which the HIV-positive partner was using suppressive antiretroviral therapy and who reported condomless sex, during a median follow-up of 1.3 years per couple, there were no documented cases of within-couple HIV transmission, according to a study appearing in the July 12 issue of JAMA, an HIV/AIDS theme issue.
HIV vaccine design should adapt as HIV virus mutates
Researchers from UAB, Emory and Microsoft demonstrate that HIV has evolved to be pre-adapted to the immune response, worsening clinical outcomes in newly infected patients.
Charlie Sheen's HIV disclosure may reinvigorate awareness, prevention of HIV
Actor Charlie Sheen's public disclosure in November 2015 that he has the human immunodeficiency virus (HIV) corresponded with the greatest number of HIV-related Google searches ever recorded in the United States, according to an article published online by JAMA Internal Medicine.

Related Hiv Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...